BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.175
0.00 (0.00%)
Sep 11, 2026, 3:32 PM CET
BioPorto Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 38.37 | 40.29 | 36.24 | 30.96 | 28.97 | 24.25 | |
Revenue Growth | 7.06% | 11.16% | 17.07% | 6.87% | 19.44% | 4.52% |
Cost of Revenue | 8.87 | 9.9 | 11.71 | 10.78 | 9.93 | 9.21 |
Gross Profit | 29.5 | 30.39 | 24.53 | 20.18 | 19.04 | 15.04 |
Selling, General & Admin | 60.01 | 58.32 | 63.05 | 54.9 | 63.05 | 50.04 |
Research & Development | 37.28 | 50.47 | 33.53 | 25.45 | 34.94 | 30.26 |
Operating Expenses | 43.15 | 108.79 | 96.58 | 80.35 | 97.99 | 80.3 |
Operating Income | -13.66 | -78.39 | -72.05 | -60.16 | -78.94 | -65.26 |
Interest Expense | - | -0.57 | -0.45 | -0.57 | -1.09 | -0.91 |
Interest & Investment Income | 1.35 | 0.51 | 1.64 | 1.04 | 0.04 | - |
Currency Exchange Gain (Loss) | -1.28 | -1.28 | 0.9 | -0.43 | 1.14 | 2.46 |
Other Non Operating Income (Expenses) | -0.21 | -0.21 | -0.38 | -0.07 | -0.12 | -0.13 |
EBT Excluding Unusual Items | -13.79 | -79.94 | -70.34 | -60.2 | -78.96 | -63.84 |
Asset Writedown | - | - | - | -1.01 | -2.58 | - |
Other Unusual Items | -7.7 | -7.7 | -3.4 | - | - | - |
Pretax Income | -21.49 | -87.64 | -73.74 | -61.21 | -81.55 | -63.84 |
Income Tax Expense | -3.53 | -5.52 | -5.5 | -4.88 | -5.62 | -6.73 |
Net Income | -17.97 | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 |
Net Income to Common | -17.97 | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 566 | 538 | 406 | 358 | 319 | 267 |
Shares Outstanding (Diluted) | 566 | 538 | 406 | 358 | 319 | 267 |
Shares Change | 30.20% | 32.47% | 13.18% | 12.54% | 19.11% | 30.21% |
EPS (Basic) | -0.03 | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 |
EPS (Diluted) | -0.03 | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -71.28 | -77.07 | -83.93 | -55.5 | -52.89 | -64.71 |
Free Cash Flow Per Share | -0.13 | -0.14 | -0.21 | -0.15 | -0.17 | -0.24 |
Gross Margin | 76.88% | 75.44% | 67.68% | 65.19% | 65.73% | 62.01% |
Operating Margin | -35.59% | -194.59% | -198.80% | -194.34% | -272.51% | -269.05% |
Profit Margin | -46.83% | -203.83% | -188.29% | -181.95% | -262.08% | -235.48% |
Free Cash Flow Margin | -185.77% | -191.29% | -231.58% | -179.26% | -182.58% | -266.79% |
EBITDA | -13.03 | -77.64 | -71.36 | -59.16 | -77.81 | -64.2 |
EBITDA Margin | -33.95% | -192.72% | -196.90% | -191.09% | -268.60% | -264.70% |
D&A For EBITDA | 0.63 | 0.75 | 0.69 | 1.01 | 1.13 | 1.05 |
EBIT | -13.66 | -78.39 | -72.05 | -60.16 | -78.94 | -65.26 |
EBIT Margin | -35.59% | -194.59% | -198.80% | -194.34% | -272.51% | -269.05% |